Processing your request

please wait...

Case Page


Case Status:    DISMISSED    
On or around 09/17/2020 (Notice of voluntarily dismissal)

Filing Date: May 29, 2020

According to the Complaint, Qiagen N.V. is the leading global provider of Sample to Insight solutions that enable customers to gain molecular insights from samples. The Company’s sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

This action stems from a proposed transaction announced on March 3, 2020, pursuant to which Qiagen will be acquired by Thermo Fisher Scientific, Inc. (“Parent”), a Delaware corporation, and Quebec B.V. (“Merger Sub,” and together with Parent, “Thermo Fisher”).

On March 3, 2020, QIAGEN’s Supervisory Board caused the Company to enter into a Business Combination Agreement with Thermo Fisher. Pursuant to the terms of the Agreement, Merger Sub commenced a tender offer to purchase all of QIAGEN’s outstanding ordinary shares for €39.00 in cash per share. The Tender Offer is set to expire on July 27, 2020.

On May 18, 2020, Defendants filed a Solicitation/Recommendation Statement with the United States Securities and Exchange Commission in connection with the Proposed Transaction. The Complaint alleges that the Solicitation Statement omits material information with respect to the Proposed Transaction, which renders the Solicitation Statement false and misleading.

On August 13, 2020, Thermo Fisher announced that its offer had lapsed. This case was voluntarily dismissed on September 17.


Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: Netherlands


Ticker Symbol: QGEN
Company Market: New York SE
Market Status: Public (Listed)

About the Company & Securities Data

"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. Delaware
DOCKET #: 20-CV-00728
JUDGE: Hon. Leonard P. Stark
DATE FILED: 05/29/2020
CLASS PERIOD END: 05/29/2020
  1. Rigrodsky & Long, P.A. (Wilmington)
  2. RM Law, P.C. (Berwyn)
No Document Title Filing Date
—Reference Complaint Complaint Related Data is not available
—Related District Court Filings Data is not available